Search research publications and outputs

  1. miR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of αv- and α6 integrin expression

    Zoni, E., van der Horst, G., van de Merbel, A. F., Chen, L., Rane, J. K., Pelger, R. C. M., Collins, A. T., Visakorpi, T., Snaar-Jagalska, B. E., Maitland, N. J. & van der Pluijm, G., 9 Apr 2015, (E-pub ahead of print)

    Article in Cancer research

  2. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context

    Chapel-Fernandes, S., Jordier, F., Lauro, F., Maitland, N., Chiaroni, J., de Micco, P., Mannoni, P. & Bagnis, C., Oct 2006

    Article in Cancer gene therapy

  3. Use of macrophages to target therapeutic adenovirus to human prostate tumors

    Muthana, M., Giannoudis, A., Scott, S. D., Fang, H-Y., Coffelt, S. B., Morrow, F. J., Murdoch, C., Burton, J., Cross, N., Burke, B., Mistry, R., Hamdy, F., Brown, N. J., Georgopoulos, L., Hoskin, P., Essand, M., Lewis, C. E. & Maitland, N. J., 1 Mar 2011

    Article in Cancer research

  4. The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

    Seed, R. I., Taurozzi, A. J., Wilcock, D. J., Nappo, G., Erb, H. H. H., Read, M. L., Gurney, M., Archer, L. K., Ito, S., Rumsby, M. G., Petrie, J. L., Clayton, A., Maitland, N. J. & Collins, A. T., 26 Mar 2019

    Article in Scientific Reports

  5. The dimerization interface of the metastasis-associated protein S100A4 (Mts1) - In vivo and in vitro studies

    Tarabykina, S., Scott, D. J., Herzyk, P., Hill, T. J., Tame, J. R. H., Kriajevska, M., Lafitte, D., Derrick, P. J., Dodson, G. G., Maitland, N. J., Lukanidin, E. M. & Bronstein, I. B., 29 Jun 2001

    Article in Journal of Biological Chemistry

  6. Targeting gene therapy for prostate cancer

    Maitland, N. J., Stanbridge, L. J. & Dussupt, V., 2004

    Literature review in Current pharmaceutical design

  7. Structure of the intact transactivation domain of the human papillomavirus E2 protein

    Antson, A. A., Burns, J. E., Moroz, O. V., Scott, D. J., Sanders, C. M., Bronstein, I. B., Dodson, G. G., Wilson, K. S. & Maitland, N. J., 17 Feb 2000

    Article in Nature

  8. STAT3 inhibition with Galiellalactone effectively targets the prostate cancer stem-like cell population."

    Canesin, G., Maggio, V., Palominos, M., Stiehm, A., Contreras, H. R., Castellón, E. A., Morote, J., Paciucci, R., Maitland, N. J., Bjartell, A. & Hellsten, R., 18 Aug 2020, (E-pub ahead of print)

    Article in Scientific Reports

  9. Robotic system for transrectal biopsy of the prostate: Real-time guidance under MRI

    Elhawary, H., Tse, ZT-H., Rea, M., Zivanovic, A., Davies, B. L., Besant, C., Desouza, N. M., Mcrobbie, D., Young, I. & Lampéerth, M. U., 2010

    Article in IEEE Engineering in Medicine and Biology Magazine

Previous 1 2 3 4 5 6 7 8 Next